Literature DB >> 10720534

Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics.

S M Standaert1, T Yu, M A Scott, J E Childs, C D Paddock, W L Nicholson, J Singleton, M J Blaser.   

Abstract

Ehrlichia chaffeensis was sought among patients with a history of tick exposure and fever, and the accuracy of other diagnostic tests was compared with that of primary isolation. Among the 38 patients enrolled, E. chaffeensis was isolated from the blood of 7 (18%) and from cerebrospinal fluid specimens of 2 of these 7. All 7 patients also were positive by polymerase chain reaction (PCR) of blood, and 6 patients developed diagnostic titers of antibody to E. chaffeensis. The isolates were characterized by molecular analysis of the 16S rRNA gene, the 120-kDa protein gene, and the variable-length PCR target (VLPT) of E. chaffeensis. On the basis of the 120-kDa and VLPT genotypes, the cerebrospinal fluid and blood isolates from the same patients were identical. This study demonstrates that both PCR and culture of blood for E. chaffeensis have high diagnostic yields. More frequent isolation of E. chaffeensis from patients with infection should further our understanding of the pathogenesis of this infection.

Entities:  

Mesh:

Year:  2000        PMID: 10720534     DOI: 10.1086/315346

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Arbobacteria - Pathogens Transmittable by Arthropods.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Detection and identification of Ehrlichia species in blood by use of PCR and electrospray ionization mass spectrometry.

Authors:  Mark W Eshoo; Chris D Crowder; Haijing Li; Heather E Matthews; Shufang Meng; Susan E Sefers; Rangarajan Sampath; Charles W Stratton; Lawrence B Blyn; David J Ecker; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

3.  Arbobacteria - Pathogens Transmittable by Arthropods.

Authors:  Lutz Gürtler; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Walter Hitzler; Bernd Jansen; Horst Klamm; Wolf-Dieter Ludwig; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2008-09-26       Impact factor: 3.747

4.  Sensitive detection of Ehrlichia chaffeensis in cell culture, blood, and tick specimens by reverse transcription-PCR.

Authors:  S Felek; A Unver; R W Stich; Y Rikihisa
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Liver Is a Generative Site for the B Cell Response to Ehrlichia muris.

Authors:  Nikita Trivedi; Florian Weisel; Shuchi Smita; Stephen Joachim; Muhamuda Kader; Aditya Radhakrishnan; Chris Clouser; Aaron M Rosenfeld; Maria Chikina; Francois Vigneault; Uri Hershberg; Nahed Ismail; Mark Jay Shlomchik
Journal:  Immunity       Date:  2019-11-12       Impact factor: 31.745

Review 6.  Progress and obstacles in vaccine development for the ehrlichioses.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

Review 7.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Multiorgan failure related to human monocytic ehrlichiosis.

Authors:  Ralph Yachoui
Journal:  BMJ Case Rep       Date:  2013-05-22

9.  Molecular heterogeneity of Ehrlichia chaffeensis isolates determined by sequence analysis of the 28-kilodalton outer membrane protein genes and other regions of the genome.

Authors:  Chuanmin Cheng; Christopher D Paddock; Roman Reddy Ganta
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 10.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.